Sandman 423
toting the rock
- Joined
- Jul 21, 2010
- Messages
- 7,863
- Likes
- 8,294
You shut your mouth. Companies should be able to price people out of life saving drugs, and arguing against that basically makes you Karl Marx.Are you serious?
What percent of insulin do you believe is purchased through health insurance plans?
Everyone with health insurance is who is currently paying the ridiculous price.
Are you serious?
What percent of insulin do you believe is purchased through health insurance plans?
Everyone with health insurance is who is currently paying the ridiculous price.
And I'm sure you would gladly support legislation limiting price gouging for life saving drugs.
Here are some solutions form your linked article:Here is a good article on why insulin is so expensive and it's not simply price gouging, it's the barriers the US government has put up to keep generics off the market. This bill will do nothing to reduce the actual price of insulin, if anything it will encourage more price gouging since the consumer won't see it at the point of sell.
Insulin insulated: barriers to competition and affordability in the United States insulin market
Here are some solutions form your linked article:
Several members of Congress have made proposals to address insulin pricing specifically. In late 2018, Senator Elizabeth Warren (D-MA) suggested that the federal government starts its own generic manufacturing plant, with insulin put forth as one product of focus.9 In July 2019, Senators Jeanne Shaheen (R-NH), Tom Carper (D-DE), Kevin Cramer (R-ND), and Susan Collins (R-ME) filed proposed legislation aimed at creating a ‘new insulin pricing model’ predominantly by regulating insulin rebates from pharmacy benefit managers.10 In February 2019, Representatives Peter Welch (D-VT) and Francis Rooney (R-FL) submitted a bill to allow importation of affordable insulin from Canada and possibly other countries.11
Sounds like we need to go after those who opposed these proposals.
Insulin is a biologic, which is a drug ‘derived from living materials, including viruses, therapeutic serums, toxins and antitoxins, vaccines, blood and blood products, and cells, tissues, and gene therapy products’.72 Most drugs are small molecule drugs, which are regulated under the Federal Food Drug and Cosmetic Act (FDCA) and approved under a New Drug Application (NDA) or associated accelerated pathway.73 Most biologics are approved through a Biologics License Application (BLA) under the Public Health Service Act (PHS Act).74 However, insulin was approved before the Food and Drug Administration (FDA) created the biologics approval process and was regulated as a small molecule drug under the FDCA until March 23, 2020.75
This regulatory inconsistency served as a practical barrier for introducing competition into the insulin market, particularly biosimilar competition. Biosimilars are drugs that are ‘highly similar to the [biologic] reference product notwithstanding minor differences in clinically inactive components’ and has ‘no clinically meaningful differences…in terms of the safety, purity, and potency of the product’ with the reference biologic.76 Under the PHS Act, biosimilars must be based on an approved reference biologic product.77 Because insulin had been regulated as a small drug, there was no reference biologic insulin product for which a biosimilar could be developed.78
California says it's going to do this.Here are some solutions form your linked article:
Several members of Congress have made proposals to address insulin pricing specifically. In late 2018, Senator Elizabeth Warren (D-MA) suggested that the federal government starts its own generic manufacturing plant, with insulin put forth as one product of focus.
California says it's going to do this.
https://cen.acs.org/pharmaceuticals/California-governor-says-state-make/100/web/2022/07
Sounds like an easy fix. Move insulin under the appropriate regulatory arm.Of course Luther stopped reading when he saw proposals to use taxpayer money and more government control to "fix" the problem.
Why doesn't the government pull it's head out of it's ass and fix the regulatory inconsistency that prevents generic insulin from coming to the market? Oh, I think we all know why.
No details were given on the location of the facility, the timetable, or the source of bulk insulin, often called drug substance.California says it's going to do this.
https://cen.acs.org/pharmaceuticals/California-governor-says-state-make/100/web/2022/07
"After all the drama of his first term and the election, everyone was enriching themselves through Trump, and he ******* hates that. It became clear after several people mentioned her name that Susie wouldn't be like that," said a person close to Trump.
Perfect.California says it's going to do this.
https://cen.acs.org/pharmaceuticals/California-governor-says-state-make/100/web/2022/07
Perhaps Republicans, unlike their liberal Democratic colleagues, actually understand basic economics and realize that price controls result in supply shortages.'What the Hell is Wrong With Them': GOP Senators Kill $35 Cap on Insulin
Republicans, doing everything they can to make average Americans hate them, then wondering why they can't win an election. No, its not because of fraud. Its because no one likes you.
Considering how cheap insulin is to manufacture, this seems unlikely. I'm sure people will be willing to make a substantial profit even if they can't make an extortionate profit.Perhaps Republicans, unlike their liberal Democratic colleagues, actually understand basic economics and realize that price controls result in supply shortages.
Considering how cheap insulin is to manufacture, this seems unlikely. I'm sure people will be willing to make a substantial profit even if they can't make an extortionate profit.
And no, Republicans aren't worried about supply shortages. They're worried about donors.